These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27618393)

  • 1. Cisplatin and Cetuximab Treatment for Metastatic Cutaneous Squamous Cell Carcinoma: A Systematic Review.
    Trodello C; Pepper JP; Wong M; Wysong A
    Dermatol Surg; 2017 Jan; 43(1):40-49. PubMed ID: 27618393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients.
    Chapalain M; Baroudjian B; Dupont A; Lhote R; Lambert J; Bagot M; Lebbe C; Basset-Seguin N
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1202-1209. PubMed ID: 31587382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center.
    Trodello C; Higgins S; Ahadiat O; Ragab O; In G; Hawkins M; Wysong A
    Dermatol Surg; 2019 Feb; 45(2):254-267. PubMed ID: 30672860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete response of metastatic cutaneous squamous cell carcinoma to cetuximab plus paclitaxel.
    Mecca C; Ponzetti A; Caliendo V; Ciuffreda L; Lista P
    Eur J Dermatol; 2012; 22(6):758-61. PubMed ID: 23131415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma.
    O'Bryan K; Sherman W; Niedt GW; Taback B; Manolidis S; Wang A; Ratner D
    J Am Acad Dermatol; 2013 Oct; 69(4):595-602.e1. PubMed ID: 23871719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.
    Jarkowski A; Hare R; Loud P; Skitzki JJ; Kane JM; May KS; Zeitouni NC; Nestico J; Vona KL; Groman A; Khushalani NI
    Am J Clin Oncol; 2016 Dec; 39(6):545-548. PubMed ID: 24879468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.
    Dereure O; Missan H; Girard C; Costes V; Guillot B
    Dermatology; 2016; 232(6):721-730. PubMed ID: 28384639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cetuximab-radiotherapy combination in the management of locally advanced cutaneous squamous cell carcinoma.
    Joseph K; Alkaabi K; Warkentin H; Ghosh S; Jha N; Smylie M; Walker J
    J Med Imaging Radiat Oncol; 2019 Apr; 63(2):257-263. PubMed ID: 30549229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
    Burgy M; Barthélémy P; Lefevre F; Dupret-Bories A; Truntzer P; Korenbaum C; Flesch H; Bronner G; Borel C
    Oncology; 2017; 93(1):11-17. PubMed ID: 28423384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cetuximab in the treatment of squamous cell carcinoma.
    Preneau S; Rio E; Brocard A; Peuvrel L; Nguyen JM; Quéreux G; Dreno B
    J Dermatolog Treat; 2014 Oct; 25(5):424-7. PubMed ID: 23167307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis of cetuximab (Erbitux) plus radiotherapy (ERT) versus concomitant cisplatin plus radiotherapy (CRT) within an NHS oncology unit (single institution): a pilot study.
    Caroline B; Sundus Y; Dawn D; Carol G; Susan M
    Br J Radiol; 2016 Dec; 89(1068):20160105. PubMed ID: 27734748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab as primary treatment for cutaneous squamous cell carcinoma to the neck.
    Kim S; Eleff M; Nicolaou N
    Head Neck; 2011 Feb; 33(2):286-8. PubMed ID: 19953623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck.
    Levy AR; Johnston KM; Sambrook J; Donato B; Penrod JR; Corral M; Chasen M
    Curr Med Res Opin; 2011 Dec; 27(12):2253-9. PubMed ID: 22017232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies--a case series.
    Eder J; Simonitsch-Klupp I; Trautinger F
    Eur J Dermatol; 2013; 23(5):658-62. PubMed ID: 24135559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.
    Bauman JE; Eaton KD; Martins RG
    Arch Dermatol; 2007 Jul; 143(7):889-92. PubMed ID: 17638733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
    Matsushita S; Kawai K; Tada K; Mera K; Kubo H; Ibusuki A; Yoshii N; Kanekura T
    J Dermatol; 2010 Jul; 37(7):666-70. PubMed ID: 20629834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies.
    Vermorken JB; Herbst RS; Leon X; Amellal N; Baselga J
    Cancer; 2008 Jun; 112(12):2710-9. PubMed ID: 18481809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinoma.
    Fury MG; Xiao H; Sherman EJ; Baxi S; Smith-Marrone S; Schupak K; Gewanter R; Gelblum D; Haque S; Schoder H; Shah JP; Katabi N; Kurtzman R; Lipson B; Cox L; Lee NY; Pfister DG
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E566-70. PubMed ID: 25784616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used.
    Ogata D; Namikawa K; Otsuka M; Asai J; Kato H; Yasuda M; Maekawa T; Fujimura T; Kato J; Takenouchi T; Nagase K; Kawaguchi M; Kaji T; Kuwatsuka Y; Shibayama Y; Takai T; Okumura M; Kambayashi Y; Yoshikawa S; Yamazaki N; Tsuchida T
    Eur J Cancer; 2020 Mar; 127():108-117. PubMed ID: 32004792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Vermorken JB; Licitra L; Stöhlmacher-Williams J; Dietz A; Lopez-Picazo JM; Hamid O; Hossain AM; Chang SC; Gauler TC
    Eur J Cancer; 2013 Sep; 49(13):2877-83. PubMed ID: 23726971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.